4 ms·
Excellent business strategy. This'll get repeat business and make sure the bottom line is strong.
by G79 5y ago
Excellent business strategy. This'll get repeat business and make sure the bottom line is strong.
- mStreamTeam 5y agoPhizer bringing planned obsolescence to the Healthcare industry
- mattkrause 5y agoIf you have a better solution, there are literally billions of dollars up for grabs. While parts of the pharma industry have definitely done shady things, the real reason we don't have a durable "cure" for many conditions is actually because the underlying biology is absurdly complex.
- mStreamTeam 5y agohttps://www.oxfam.org/en/press-releases/covid-vaccines-create-9-new-billionaires-combined-wealth-greater-cost-vaccinating https://www.oxfam.org/en/press-releases/covid-vaccines-creat... It's a little late for that. Phizer has already taken all those billions of dollars. Not sure the government can afford to hand out a few more billion without making inflation even worse
- brandon272 5y agoA few billion isn't going to have any impact on inflation that is worth worrying about if there is real headway made on COVID. It's the trillions that are probably worth worrying about.
- cromka 5y agoIt’s only excellent if you don’t have competition. And they do. Anyone offering a significantly longer-lasting protection would effectively put them out of COVID business.
- mattkrause 5y agoAnd there's a fair bit of competition: Moderna, AstraZeneca, Johnson and Johnson, plus the 88 other ones in various stages of development: https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker https://www.raps.org/news-and-articles/news-articles/2020/3/... If there were an easy route to a durable vaccine, I can't imagine that someone wouldn't have tried to take over that entire market instead of settling for a drip here and there. You could charge a lot more (see also: SMA and Hepatitis C treatments) and the value to the brand ("From the people who ended the pandemic...") would be amazing.
- touisteur 5y agoYou're doing the Lord's work here and I'm here to say I regret I can't upvote you more. For all the permanent talk about Hanlon's Razor in here, it seems to all have gone out the window. As if there wouldn't be dozens of pharma researchers whistleblowing 'we have the cure but our lab won't sell it'. An annual vaccine is what mostly works for the flu, and nobody but cranks was talking about labs not really wanting to cure the flu. It's just so damn hard. Now everything is easy? they just decided not to save us?
- cromka 5y ago> As if there wouldn't be dozens of pharma researchers whistleblowing 'we have the cure but our lab won't sell it'. Precisely: lack of information is also an information. Such a simple, even beautiful way to look at things, yet so commonly ignored.
- isolli 5y agoYet for some reason, people seem to prefer the Pfizer vaccines. Governments too; I'm not following closely but it looks like governments are dragging their feet authorizing and buying available alternatives such as Novavax (spike protein) and Valneva (de-activated virus). Which is a shame, because it could convince those unsure about mRNA technology to get vaccinated.